arrow
A

Alessandro Larcher

Vita-Salute San Raffaele University
H指数:49
被引数:8,510

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL-PNRR-POC-2023-12377493)

首次人体外研究验证碳酸酐酶IX-PET在高风险肾癌中的应用(CAT-VHL-PNRR-POC-2023-12377493)

2026-05-180
PRE
KURADS (KIDNEY UROLOGIC ASSESSMENT DATA SCORE): LEVELING UP PREDICTION OF HIGH-RISK RCC IN SOLID RENAL MASSES

KURADS(肾脏泌尿系统评估数据评分):提高实体肾肿块中高风险肾细胞癌的预测水平

2026-05-010
PRE
A STEP FORWARD IN RCC STAGING: EXTERNAL VALIDATION OF THE EAU-PROPOSED M STAGING

肾细胞癌分期的一大步:对欧洲泌尿外科学会(EAU)提议的M分期的外部验证

2026-05-010
PRE
MULTIDISCIPLINARY MANAGEMENT OF VON HIPPEL-LINDAU DISEASE THROUGHOUT THE PATIENT'S LIFETIME: OBSERVATIONAL ANALYSIS FROM A LARGE COMPREHENSIVE CARE CENTER

von Hippel-Lindau疾病的多学科终身管理:来自大型综合护理中心的观察分析

2026-05-010
PRE
COMPARATIVE PROGNOSTIC PERFORMANCE OF KEYNOTE-564 AND AUA RISK STRATIFICATION IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA

比较KEYNOTE-564与AUA风险分层在非转移性透明细胞肾细胞癌中的预后性能

2026-05-010
PRE
ROBOTIC VS. OPEN PARTIAL NEPHRECTOMY IN COMPLEX CASES: REAL WORLD BENCHMARKING OF THE OPERA TRIAL

机器人辅助与开放性部分肾切除术在复杂病例中的比较:OPERA试验的真实世界基准评估

2026-05-010
PRE
SURGERY ON THE EDGE: REAL-WORLD OUTCOMES OF PARTIAL AND RADICAL NEPHRECTOMY IN PATIENTS WITH STAGE 4 CHRONIC KIDNEY DISEASE

手术的边缘:慢性肾病4期患者行部分肾切除术与根治性肾切除术的真实世界结局

2026-05-010
PRE
xA RISK-BASED MODEL TO IDENTIFY ACTIVE SURVEILLANCE PATIENTS REQUIRING CONFIRMATORY BIOPSY: A CONTEMPORARY MRI-BASED COHORT STUDY

基于风险模型的主动监测患者确认性活检需求识别:一项当代基于MRI的队列研究

2026-05-010
PRE
WHEN THE THROMBUS RISES: INFERIOR VENA CAVA INVOLVEMENT IMPAIRS PREOPERATIVE RENAL FUNCTION IN RENAL CELL CARCINOMA

当血栓升高:下腔静脉受累损害肾细胞癌患者的术前肾功能

2026-05-010
PRE
RENAL FUNCTIONAL FOLLOWING ANGIOEMBOLIZATION AFTER PARTIAL NEPHRECTOMY

部分肾切除术后行血管栓塞术后的肾功能

2026-05-010
PRE
PROGNOSTIC IMPLICATIONS OF NODAL STATUS IN LOCALIZED AND LOCALLY-ADVANCED RENAL CELL CARCINOMA: ANALYSIS FROM THE NCDB

淋巴结状态在局部性和局部进展性肾细胞癌中的预后意义:NCDB数据分析

2026-05-010
PRE
PERSONALIZED PREDICTORS OF RENAL RECOVERY AFTER PARTIAL NEPHRECTOMY

部分肾切除术后肾功能恢复的个性化预测因子

2026-05-010
PRE
REFINING SURVEILLANCE FOR SMALL RENAL MASSES: PREDICTING AGGRESSIVENESS AND ONCOLOGIC OUTCOMES BASED ON TUMOUR SIZE AND PATIENT CHARACTERISTICS

优化小肾肿瘤的观察随访:基于肿瘤大小和患者特征预测侵袭性和肿瘤学结局

2026-05-010
PRE
POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY: STILL A REAL CONCERN OR A FADING THREAT?

部分肾切除术后的阳性手术切缘:仍然是一个真实的问题还是逐渐消失的威胁?

2026-05-010
PRE
CYTOREDUCTIVE NEPHROURETERECTOMY PLUS SYSTEMIC THERAPY VERSUS SYSTEMIC THERAPY ALONE IN METASTATIC UTUC: AN NCDB PROPENSITY-SCORE MATCHED ANALYSIS

细胞减灭性肾输尿管切除术联合全身治疗与仅全身治疗在转移性上尿路尿路上皮癌中的比较:一项NCDB倾向性评分匹配分析

2026-05-010
PRE
IMPACT OF HISTOLOGICAL SUBTYPE AND METASTATIC BURDEN ON OVERALL SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RCC IN THE IMMUNOTHERAPY ERA: INSIGHTS FROM THE NATIONAL CANCER DATABASE

免疫治疗时代下,组织学亚型和转移负荷对根治性肾细胞癌细胞减灭术患者总生存期的影响:基于国家癌症数据库的见解

2026-05-010
PRE
TOWARDS GENDER EQUITY IN RENAL SURGERY: UNDERSTANDING SEX-BASED DIFFERENCES IN PERIOPERATIVE OUTCOMES

迈向肾脏手术中的性别平等:理解围手术期结果的性别差异

2026-05-010
PRE
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinoma

非转移性透明细胞肾细胞癌中KEYNOTE-564与AUA风险分层的比较预后性能

2026-01-010
PRE
Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis

局部肾细胞癌女性患者行部分或根治性肾切除术后的生存与复发预测因素:一项多中心分析

2026-01-010
PRE